abstract |
The invention is directed to modified HIV-l envelopes, compositions comprising these modified envelopes, nucleic acids encoding these modified envelopes, compositions comprising these nucleic acids, and methods of using these modified HIV-l envelopes and/or these nucleic acids to induce immune responses. |